Compare Amylx Pharmaceuticals Inc (AMLX) vs Redwire Corporation (RDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Redwire Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Redwire Corporation trades at $13.62 (market cap $3.38B). The key difference: Redwire Corporation is the larger of the two by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Redwire Corporation nearer its low. Which is the better fit depends on your goals.
| AMLX | RDW | |
|---|---|---|
Market Cap | $2.64B | $3.38B |
Sector | Health | Technology |
52-Week High | $24.19 | $25.90 |
52-Week Low | $7.82 | $5.06 |
Enterprise Value | $2.39B | $2.91B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →
